Advocacy
T1D Women Inc. Advocates For People With Type 1 Diabetes
11/9/2026- Letter
Improving Access to Deceased Donor Islet Transplants for Type 1 Diabetes
Following advocacy from Breakthrough T1D and other organizations, the U.S. Department of Health and Human Services, FDA, and HRSA have issued a request for public input on reclassifying deceased donor islets (DDIs) from drugs to organs for transplantation.
Currently, deceased donor islets are classified as drugs, creating regulatory barriers that limit access to transplantation. Reclassifying them as organs could make this therapy more accessible to people with type 1 diabetes who qualify.
Islet transplantation has the potential to restore insulin production and, for some recipients, eliminate the need for insulin.
T1D Women, Inc. supports this effort and has submitted a public comment letter. Read our letter below.
10/16/2026-Email
Dexcom Terms of Policy Update
On behalf of T1D Women, Inc., a 501(c)(3) nonprofit organization dedicated to supporting and advocating for women and girls living with type 1 diabetes (T1D), we are writing to express serious concerns about the updated Terms of Use and Privacy Notice for the Dexcom mobile app. These changes raise important questions about patient privacy, legal rights, informed consent, and continued access to essential diabetes technology.